| # | Drug | Count |
|---|---|---|
| 0 | EPOPROSTENOL | 524 |
| 1 | MACITENTAN | 336 |
| 2 | SILDENAFIL CITRATE | 279 |
| 3 | TADALAFIL | 232 |
| 4 | TREPROSTINIL | 184 |
| 5 | SILDENAFIL | 173 |
| 6 | AMBRISENTAN | 145 |
| 7 | FUROSEMIDE | 110 |
| 8 | SILDENAFIL POWDER, | 110 |
| 9 | BOSENTAN | 104 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | EPOPROSTENOL | 524 | 0.0400 |
| 1 | MACITENTAN | 336 | 0.0048 |
| 2 | SILDENAFIL POWDER, | 110 | 0.0031 |
| 3 | RIOCIGUAT | 98 | 0.0030 |
| 4 | OXACILLIN SODIUM | 3 | 0.0026 |
| 5 | TADALAFIL | 232 | 0.0023 |
| 6 | SILDENAFIL CITRATE | 279 | 0.0022 |
| 7 | SELEXIPAG | 55 | 0.0021 |
| 8 | BOSENTAN | 104 | 0.0021 |
| 9 | CEFACLOR | 3 | 0.0019 |
| # | Drug class | Count |
|---|---|---|
| 0 | Prostacycline Vasodilator [EPC] | 662 |
| 1 | Endothelin Receptor Antagonist [EPC] | 473 |
| 2 | Phosphodiesterase 5 Inhibitor [EPC] | 324 |
| 3 | Loop Diuretic [EPC] | 136 |
| 4 | Factor Xa Inhibitor [EPC] | 100 |
| 5 | Soluble Guanylate Cyclase Stimulator [EPC] | 98 |
| 6 | Aldosterone Antagonist [EPC] | 72 |
| 7 | Corticosteroid [EPC] | 58 |
| 8 | Prostacyclin Receptor Agonist [EPC] | 55 |
| 9 | Osmotic Laxative [EPC] | 52 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Prostacycline Vasodilator [EPC] | 662 | 0.0048 |
| 1 | Soluble Guanylate Cyclase Stimulator [EPC] | 98 | 0.0029 |
| 2 | Phosphodiesterase 5 Inhibitor [EPC] | 324 | 0.0024 |
| 3 | Endothelin Receptor Antagonist [EPC] | 473 | 0.0024 |
| 4 | Prostacyclin Receptor Agonist [EPC] | 55 | 0.0021 |
| 5 | Macrolide Antibacterial [EPC] | 1 | 0.0010 |
| 6 | Plasma Kallikrein Inhibitor [EPC] | 2 | 0.0008 |
| 7 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 10 | 0.0007 |
| 8 | Provitamin D2 Compound [EPC] | 21 | 0.0007 |
| 9 | Antiseptic [EPC] | 3 | 0.0007 |